---
figid: PMC4322985__oncotarget-05-11752-g006
figtitle: 'BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential
  signalling and therapeutic implications'
organisms:
- NA
pmcid: PMC4322985
filename: oncotarget-05-11752-g006.jpg
figlink: /pmc/articles/PMC4322985/figure/F6/
number: F6
caption: '[, , ]. (A) Inhibitors of the key downstream effectors of RAS. All downstream
  RAS effectors are cytosolic protein kinases that form a tiered protein kinase cascade
  downstream of RAS. (B) The resistance mechanism against BRAF inhibitor vemurafenib
  (PLX4032).'
papertitle: 'BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential
  signalling and therapeutic implications.'
reftext: Eftychia Oikonomou, et al. Oncotarget. 2014 Dec;5(23):11752-11777.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.954524
figid_alias: PMC4322985__F6
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC4322985__F6
ndex: bbc46986-de9b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4322985__oncotarget-05-11752-g006.html
  '@type': Dataset
  description: '[, , ]. (A) Inhibitors of the key downstream effectors of RAS. All
    downstream RAS effectors are cytosolic protein kinases that form a tiered protein
    kinase cascade downstream of RAS. (B) The resistance mechanism against BRAF inhibitor
    vemurafenib (PLX4032).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - gt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - Crtc
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - rl
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - AGL
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - MTOR
  - RPTOR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - Temsirolimus
  - PD-0325901
  - Ridaforolimus
  - Selumetinib
  - AZD8055
  - Trametinib
  - GSK2118436
  - Dabrafenib
  - GDC0980
  - AZD2014
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
